Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Bioanalysis is Scopus-indexed (Q2, CiteScore 3), WoS SCIE. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1757-6180Verify ISSN ↗1757-6199Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medical Laboratory Technology | 17 / 42 | 60th | Q2 |
| Pharmacology, Toxicology and Pharmaceutics (all) | 34 / 79 | 57th | Q2 |
| Clinical Biochemistry | 84 / 124 | 32nd | Q3 |
| Analytical Chemistry | 113 / 160 | 29th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q2, CiteScore 3.
Bioanalysis is Q2 in Medical Laboratory Technology (rank 17 of 42), Q2 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 34 of 79) and Q3 in Clinical Biochemistry (rank 84 of 124), by CiteScore 2025. It is ranked in 4 subject areas in all.
Bioanalysis is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3, which places it in quartile Q2 at the 60th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.375, quartile Q2, with an H-index of 77.
Bioanalysis is published by Taylor and Francis Ltd. Its print ISSN is 1757-6180 and its online ISSN is 1757-6199.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Bioanalysis has an h-index of 83 and a 2-year mean of 2.61 citations per paper (OpenAlex). Its Scopus CiteScore is 3, quartile Q2. On 2-year citations it ranks #7 of 42 Scopus journals in Medical Laboratory Technology.
Bioanalysis published 150 papers in 2025; its busiest recent year was 2019 with 212. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 91 research articles (2025–2026), authors are most often from United States (27.7%), China (12.5%) and Switzerland (5.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.